Profit Taking Sinks Peregrine Pharmaceuticals
Profit taking sank shares of Peregrine Pharmaceuticals Inc. (Nasdaq: PPHM) 29 cents to $2.04, whose stock price climbed on Monday after clarifying study data for its lung cancer treatment bavituximab.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here